Step by step for bringing a taxi:
1. Posted mana2 course list PSV driving schools ... METRO at Kelang fees he about RM 300 + + if not mistaken compare with the class of ordinary driven Reach 6-7 hundred ....
2. at the list, enter 15 hours of practical classes coats ...
3. Facet grade, in exam .... this is difficult ... sexy people following tricky question ... public and third paper Second..
p / s: want to pass the tips .. read and understand all the books and notes he wrote for .. pastu must know the current news esp Chapter 2 and Chapter 2 the ministry of tourism .. be diligent in reading the newspaper
repeat if not mistaken paper to pay RM 35 coats ...
4. already passed, looking for a taxi company who offer mana2 rent / buy / sell a taxi .... register with them following the new licensee unfit taxis permit camp ... permit companies to put .. Posted at drive Taxi 3 new cholera apply taxi permit from RTD coat ...
5. deposit rates: between RM 3000-RM 5000
6. They take a taxi and do not forget to pay your daily rental of RM 36-RM 50 + +
7. Income per day (8 am - 4 pm) Posted to rate at least RM 100
tips:
- Tips on good income Posted camp .. org jgn duk kat bus stop waiting .. ler slow2 way around the place that you cover though ...
- Another tip org message, please do not join org duk like a coffee shop hang out, play games, tikam2, catering ... always waste the time is not enough money when a taxi carrying this Loaded know if hard to keep ...
- Daily money than to pay rent, have to save for the future .. if not save it, difficult, if not suddenly stuck bawak day cab
- For more information, go la at for a taxi company who whenever they see the package offer
- Sent using Google Toolbar"
Welcome to my our blog,this blog I like to share about my story.If you have read my info thanks for your reading.
Sunday, October 24, 2010
Wednesday, October 20, 2010
Friday, April 30, 2010
The flu not over
"The flu season is not over yet ... H1N1 has remained persistent in the southeast and now those states are experiencing more local and regional activity," U.S. Surgeon General Regina Benjamin told reporters in a conference call.
U.S. health officials said it was not clear why there were more swine flu cases in some regions and warned that many people were still vulnerable because they had not been immunized.
Alabama, South Carolina and Georgia have been reporting "regional disease" - one step below "widespread disease," Dr. Anne Schucha of the U.S. Centers for Disease Control and Prevention said on the call. She said the situation in Georgia was unique.
"Recently, Georgia has seen more laboratory confirmed influenza hospitalizations each week than they've seen at any time since October," Schuchat said.
"They've had more than 40 hospitalizations in this past week, and for the third week in a row, Georgia had more hospitalizations than any other state in the country from laboratory-confirmed H1N1 influenza," Schuchat said.
Most of the people affected were adults with chronic health conditions and people who had not been immunized, Schuchat said. Georgia was among the states with the lowest rate of vaccinations, she said.
Benjamin again urged people to get immunized and said that the vaccine was in plentiful supply.
The U.S. supply of H1N1 vaccine reached 124 million doses last week, Benjamin said.
Swine flu has killed an estimated 12,000 Americans and put more than 265,000 into the hospital, according to CDC. It has largely displaced seasonal flu strains in the current flu season. Seasonal flu kills about 36,000 people in the United States each year and puts 200,000 in the hospital.
Swine flu emerged a year ago in the United States and Mexico and spread around the world in just six weeks, killing thousands of people. It hit children and young adults especially hard.
Although H1N1 activity has declined in the Americas and Europe, the World Health Organization says it is still technically causing a pandemic.
U.S. health officials said it was not clear why there were more swine flu cases in some regions and warned that many people were still vulnerable because they had not been immunized.
Alabama, South Carolina and Georgia have been reporting "regional disease" - one step below "widespread disease," Dr. Anne Schucha of the U.S. Centers for Disease Control and Prevention said on the call. She said the situation in Georgia was unique.
"Recently, Georgia has seen more laboratory confirmed influenza hospitalizations each week than they've seen at any time since October," Schuchat said.
"They've had more than 40 hospitalizations in this past week, and for the third week in a row, Georgia had more hospitalizations than any other state in the country from laboratory-confirmed H1N1 influenza," Schuchat said.
Most of the people affected were adults with chronic health conditions and people who had not been immunized, Schuchat said. Georgia was among the states with the lowest rate of vaccinations, she said.
Benjamin again urged people to get immunized and said that the vaccine was in plentiful supply.
The U.S. supply of H1N1 vaccine reached 124 million doses last week, Benjamin said.
Swine flu has killed an estimated 12,000 Americans and put more than 265,000 into the hospital, according to CDC. It has largely displaced seasonal flu strains in the current flu season. Seasonal flu kills about 36,000 people in the United States each year and puts 200,000 in the hospital.
Swine flu emerged a year ago in the United States and Mexico and spread around the world in just six weeks, killing thousands of people. It hit children and young adults especially hard.
Although H1N1 activity has declined in the Americas and Europe, the World Health Organization says it is still technically causing a pandemic.
Monday, January 4, 2010
The developing world is still waiting for swine flu vaccine
The WHO director-general, Margaret Chan, has said that the swine flu — influenza A(H1N1) — pandemic may not be conquered until 2011.
She said it was "prudent and appropriate" to monitor the evolution of the virus for the next 12 months, Reuters reported last week (29 December).
Cases have peaked in the United Kingdom, Canada and the United States, she said, but are still increasing in countries such as Egypt and India.
Keiji Fukuda, the WHO's special advisor on swine flu, said last month (19 December) that logistical and regulatory issues caused delays in distributing A(H1N1) vaccines to the developing world [46kB].
The organisation had planned to start sending vaccine in November, with Afghanistan, Azerbaijan and Mongolia first in line, said Fukuda.
Chan added that the decision by AstraZeneca and Sanofi-Aventis to recall some A(H1N1) vaccine because it was not potent enough was not related to vaccine safety.
As vaccine becomes increasingly available, the required number of doses is still being debated. The Lancet published three studies last month (16 December) from China* and Hungary* and the United States*. All three say that one dose is enough for an adult but that children (under nine in the US study and under 12 in the Chinese study) need two. The Hungarian study did not include children.
But an Australian study, to be published in the Journal of the American Medical Association this week (6 January), found that one dose is effective in children older than six months.
The New England Journal of Medicine reported last month (31 December) that young people are more likely to catch A(H1N1) — but are not more likely to spread it.
People under 18 are twice as likely to catch swine flu from members of their household than those aged 19–50 but are no more likely to pass it on.
US scientists have mapped the interaction between human and A(H1N1) cells. Their study, published in Cell (17 December), will guide future studies, they said.
And a small human protein called IFITM might explain why some people shrug off influenza A(H1N1) while others die. US researchers said that the more IFITM a person has, the better.
Stephen Elledge, lead author of the study, also published in Cell (17 December), said the virus replicates 5–10 times more efficiently in the absence of IFITM.
A collaboration between Canadian and Spanish researchers has found that patients with severe A(H1N1) infections have high levels of interleukin-17, a chemical that helps white blood cells fight infection and disease.
The research, published in the journal Critical Care (24 December), could lead to the development of a drug that blocks interleukin-17 to prevent severe cases of A(H1N1).
People with underlying health problems, such as a weak heart or cancer, need prompt, intensive treatment including antibiotic and antiviral drugs when they catch influenza A(H1N1), according to an autopsy study of 21 people who died from the virus.
The Brazilian research was published in the American Journal of Respiratory and Critical Care Medicine this month (1 January).Info by News buletin.
The WHO director-general, Margaret Chan, has said that the swine flu — influenza A(H1N1) — pandemic may not be conquered until 2011.
She said it was "prudent and appropriate" to monitor the evolution of the virus for the next 12 months, Reuters reported last week (29 December).
Cases have peaked in the United Kingdom, Canada and the United States, she said, but are still increasing in countries such as Egypt and India.
Keiji Fukuda, the WHO's special advisor on swine flu, said last month (19 December) that logistical and regulatory issues caused delays in distributing A(H1N1) vaccines to the developing world [46kB].
The organisation had planned to start sending vaccine in November, with Afghanistan, Azerbaijan and Mongolia first in line, said Fukuda.
Chan added that the decision by AstraZeneca and Sanofi-Aventis to recall some A(H1N1) vaccine because it was not potent enough was not related to vaccine safety.
As vaccine becomes increasingly available, the required number of doses is still being debated. The Lancet published three studies last month (16 December) from China* and Hungary* and the United States*. All three say that one dose is enough for an adult but that children (under nine in the US study and under 12 in the Chinese study) need two. The Hungarian study did not include children.
But an Australian study, to be published in the Journal of the American Medical Association this week (6 January), found that one dose is effective in children older than six months.
The New England Journal of Medicine reported last month (31 December) that young people are more likely to catch A(H1N1) — but are not more likely to spread it.
People under 18 are twice as likely to catch swine flu from members of their household than those aged 19–50 but are no more likely to pass it on.
US scientists have mapped the interaction between human and A(H1N1) cells. Their study, published in Cell (17 December), will guide future studies, they said.
And a small human protein called IFITM might explain why some people shrug off influenza A(H1N1) while others die. US researchers said that the more IFITM a person has, the better.
Stephen Elledge, lead author of the study, also published in Cell (17 December), said the virus replicates 5–10 times more efficiently in the absence of IFITM.
A collaboration between Canadian and Spanish researchers has found that patients with severe A(H1N1) infections have high levels of interleukin-17, a chemical that helps white blood cells fight infection and disease.
The research, published in the journal Critical Care (24 December), could lead to the development of a drug that blocks interleukin-17 to prevent severe cases of A(H1N1).
People with underlying health problems, such as a weak heart or cancer, need prompt, intensive treatment including antibiotic and antiviral drugs when they catch influenza A(H1N1), according to an autopsy study of 21 people who died from the virus.
The Brazilian research was published in the American Journal of Respiratory and Critical Care Medicine this month (1 January).Info by News buletin.
Subscribe to:
Posts (Atom)
Collection in my blog
Probably my most constructive hobby is writing. I've never really went "public" with my work, so I guess now is as good a time as any. I have probablythree uncompleted stories in my collection now, so every few days or weeks or whenever I get time, I'll add a new story or a chapter to a previous one. If you wish to comment on a story, do so at the link on the bottom of the page. Or, I wouldbe happy to post one of your stories, too! Thanks. :)
Blog Archive
-
►
2012
(1)
- ► 11/18 - 11/25 (1)
-
►
2009
(1)
- ► 07/19 - 07/26 (1)
-
►
2007
(1)
- ► 06/03 - 06/10 (1)